Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation

P. Alexander Compton, Ahmad A. Zankar, Adebola O. Adesanya, Subhash Banerjee, Emmanouil S. Brilakis

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57% sirolimus-eluting stents and 43% paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34% abdominal, 22% vascular, 17% genitourinary, and 27% other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44% skin surgery, 44% injections, and 12% other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0%, 95% confidence interval 0% to 9%) and 18 minor noncardiac (0%, 95% confidence interval 0% to 19%) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.

Original languageEnglish (US)
Pages (from-to)1212-1213
Number of pages2
JournalAmerican Journal of Cardiology
Volume98
Issue number9
DOIs
StatePublished - Nov 1 2006

Fingerprint

Drug-Eluting Stents
Minor Surgical Procedures
Stents
Confidence Intervals
Dermatologic Surgical Procedures
Veterans
Sirolimus
Paclitaxel
Sample Size
Blood Vessels
Injections

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation. / Compton, P. Alexander; Zankar, Ahmad A.; Adesanya, Adebola O.; Banerjee, Subhash; Brilakis, Emmanouil S.

In: American Journal of Cardiology, Vol. 98, No. 9, 01.11.2006, p. 1212-1213.

Research output: Contribution to journalArticle

Compton, P. Alexander ; Zankar, Ahmad A. ; Adesanya, Adebola O. ; Banerjee, Subhash ; Brilakis, Emmanouil S. / Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation. In: American Journal of Cardiology. 2006 ; Vol. 98, No. 9. pp. 1212-1213.
@article{dca7dbe3992a45a68141821375d93812,
title = "Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation",
abstract = "We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57{\%} sirolimus-eluting stents and 43{\%} paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34{\%} abdominal, 22{\%} vascular, 17{\%} genitourinary, and 27{\%} other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44{\%} skin surgery, 44{\%} injections, and 12{\%} other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0{\%}, 95{\%} confidence interval 0{\%} to 9{\%}) and 18 minor noncardiac (0{\%}, 95{\%} confidence interval 0{\%} to 19{\%}) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.",
author = "Compton, {P. Alexander} and Zankar, {Ahmad A.} and Adesanya, {Adebola O.} and Subhash Banerjee and Brilakis, {Emmanouil S.}",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.amjcard.2006.05.050",
language = "English (US)",
volume = "98",
pages = "1212--1213",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation

AU - Compton, P. Alexander

AU - Zankar, Ahmad A.

AU - Adesanya, Adebola O.

AU - Banerjee, Subhash

AU - Brilakis, Emmanouil S.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57% sirolimus-eluting stents and 43% paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34% abdominal, 22% vascular, 17% genitourinary, and 27% other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44% skin surgery, 44% injections, and 12% other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0%, 95% confidence interval 0% to 9%) and 18 minor noncardiac (0%, 95% confidence interval 0% to 19%) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.

AB - We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57% sirolimus-eluting stents and 43% paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34% abdominal, 22% vascular, 17% genitourinary, and 27% other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44% skin surgery, 44% injections, and 12% other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0%, 95% confidence interval 0% to 9%) and 18 minor noncardiac (0%, 95% confidence interval 0% to 19%) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.

UR - http://www.scopus.com/inward/record.url?scp=33750084402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750084402&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2006.05.050

DO - 10.1016/j.amjcard.2006.05.050

M3 - Article

C2 - 17056330

AN - SCOPUS:33750084402

VL - 98

SP - 1212

EP - 1213

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -